Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Cano-Blanco

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gaceta Medica De Mexico|December 3, 2019
Experiencia con el uso de olaparib en pacientes con cáncer de ovarioDolores Gallardo-Rincón, Gabriela Alamilla-García, Edgar Montes-Servín, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 27, 2018
Effects of Dietary Components During and After Concomitant Chemoradiotherapy, Radiotherapy, or Sequential Chemoradiotherapy to the Abdominopelvic AreaLaura Flores-Cisneros, Denisse Castro-Eguiluz, Diana Yolanda Reyes-Barretero, et al.
Frontiers in Genetics|June 23, 2022
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation <i>BRCA1</i>-Del ex9-12Dolores Gallardo-Rincón, Edgar Montes-Servín, Gabriela Alamilla-García, et al.
Salud Publica De Mexico|October 28, 2025
Flavia Morales-Vazquez, Claudia Cano-Blanco, Milagros Pérez-Quintanilla, et al.
Cirugia Y Cirujanos|October 20, 2025
Second Mexican Consensus on Endometrial CancerDavid F Cantú-de León, Flavia Morales-Vásquez, Claudia Cano-Blanco, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gaceta Medica De Mexico|December 3, 2019
Experiencia con el uso de olaparib en pacientes con cáncer de ovarioDolores Gallardo-Rincón, Gabriela Alamilla-García, Edgar Montes-Servín, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 27, 2018
Effects of Dietary Components During and After Concomitant Chemoradiotherapy, Radiotherapy, or Sequential Chemoradiotherapy to the Abdominopelvic AreaLaura Flores-Cisneros, Denisse Castro-Eguiluz, Diana Yolanda Reyes-Barretero, et al.
Frontiers in Genetics|June 23, 2022
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation <i>BRCA1</i>-Del ex9-12Dolores Gallardo-Rincón, Edgar Montes-Servín, Gabriela Alamilla-García, et al.
Salud Publica De Mexico|October 28, 2025
Flavia Morales-Vazquez, Claudia Cano-Blanco, Milagros Pérez-Quintanilla, et al.
Cirugia Y Cirujanos|October 20, 2025
Second Mexican Consensus on Endometrial CancerDavid F Cantú-de León, Flavia Morales-Vásquez, Claudia Cano-Blanco, et al.
Pageof 1